alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE COMPANY'S
FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-31-1999
<PERIOD-START>                                 JAN-01-1999
<PERIOD-END>                                   JUN-30-1999
<CASH>                                         50,907,296
<SECURITIES>                                   0
<RECEIVABLES>                                  25,000
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               51,254,060
<PP&E>                                         4,148,482
<DEPRECIATION>                                 (586,766)
<TOTAL-ASSETS>                                 56,000,685
<CURRENT-LIABILITIES>                          1,449,265
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       17,185
<OTHER-SE>                                     54,534,235
<TOTAL-LIABILITY-AND-EQUITY>                   56,000,685
<SALES>                                        0
<TOTAL-REVENUES>                               27,171
<CGS>                                          0
<TOTAL-COSTS>                                  5,989,799
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             216,182
<INCOME-PRETAX>                                (6,129,059)
<INCOME-TAX>                                   2,824,069
<INCOME-CONTINUING>                            (3,304,990)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (3,304,990)
<EPS-BASIC>                                  (0.25)
<EPS-DILUTED>                                  (0.25)



</TABLE>
EXHIBIT 23.2



CONSENT OF PRICE WATERHOUSE LLP




We  hereby  consent  to the  incorporation  by  reference  in  the  Registration
Statements  on  Form  S-8  (Nos.  2-92053,   33-2171,  33-17848  (Post-Effective
Amendment No. 1), 33-33803,  33-33807,  33-39323,  33-36911, 33-45176, 33-45231,
33-45233,  33-56952,  33-58708, 33-72158, 33-55265 (Post-Effective Amendment No.
1),  33-60379,  33-63547,  333-11639 and  333-15923) of 3Com  Corporation of our
report dated  February 7, 1995 relating to the  financial  statements of Chipcom
Corporation and of our report on the Financial Statement Schedule, which reports
are included as exhibits to this Annual Report on Form 10-K.


/s/ Price Waterhouse LLP
------------------------
PRICE WATERHOUSE LLP

Boston, Massachusetts
August 22, 1997
From: frank.mooney@oilstates.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:15:15 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Frank X. Mooney

Friendswood, TX 77546
<page>
			            EXHIBIT 32.02


CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the Annual Report of Dean Witter Cornerstone
Fund III (the "Partnership") on Form 10-K for the period ended
December 31, 2003 as filed with the Securities and Exchange
Commission on the date hereof (the "Report"), I, Jeffrey D. Hahn,
Chief Financial Officer, Demeter Management Corporation, the
general partner of the Partnership, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002, that, to the best of my knowledge:
(1)	The Report fully complies with the requirements of Section
13 or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents,
in all material respects, the financial condition and
results of operations of the Partnership.








By:	  /s/	Jeffrey D. Hahn

Name:		Jeffrey D. Hahn
Title:	Chief Financial Officer

Date:		March 30, 2004
---

CERTIFICATION OFCHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER 
  PURSUANT TO18 U.S.C. SECTION 1350, 
  AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Daniel Hunter, the Chief Executive Officer and Chief Financial
  Officer of Encore Clean Energy, Inc. (the “Company”), hereby certify
  pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
  Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

| | (i)  | the Quarterly Report on Form 10-QSB of the Company,
        for the fiscal quarter ended March 31, 2005, and to which this certification
        is attached as Exhibit 32.1 (the “Report”) fully complies
        with the requirements of Section 13(a) or 15(d) of the Securities Exchange
        Act of 1934, as amended; and
| | ---- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |      |                                                                                                                                                                                                                                                                                                                                   
| | (ii) | the information contained in the Report fairly presents,
        in all material respects, the financial condition and results of operations
        of the Company.                                                                                                                                                              

| | By:    | /s/ Daniel B. Hunter             
| | ------ | ---------------------------------
| |        |                                  
| | Name:  | DANIEL B. HUNTER                 
| |        |                                  
| | Title: | Chief Executive Officer and Chief
| |        | Financial Officer                
| |        |                                  
| | Date:  | June 14, 2005                    

A signed original of this written statement required by
  Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company
  and will be retained by the Company and furnished to the Securities and Exchange
  Commission or its staff upon request.

This certification accompanies the Form 10-QSB to which
  it relates, is not deemed filed with the Securities and Exchange Commission
  and is not to be incorporated by reference into any filing of the Company under
  the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made
  before or after the date of the Form 10-QSB), irrespective of any general incorporation
  language contained in such filing.

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

                    Notice is hereby given of a change in the meeting of the National Advisory Council on Drug Abuse, September 12, 2023, 10:30 a.m. to September 12, 2023, 05:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 which was published in the                     **Federal Register**                     on August 21, 2023, FR Doc 2023-17889, 88 FR 56847.                

This notice is being amended to change the open session start time from 12:45 p.m. to 1:00 p.m. The open session will now be held from 1:00 p.m. to 5:00 p.m. on September 12, 2023. The meeting is partially closed to the public.

Dated: September 1, 2023. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-19406 Filed 9-7-23; 8:45 am]

BILLING CODE 4140-01-P
## SUPREME COURT OF THE STATE OF NEW YORK 

## Appellate Division, Fourth Judicial Department

1435 TP 11-01442 PRESENT: SCUDDER, P.J., CENTRA, GREEN, GORSKI, AND MARTOCHE, JJ.

IN THE MATTER OF HENRY HUDSON, PETITIONER,

V ORDER

ANDREA W. EVANS, CHAIRWOMAN, NEW YORK STATE DIVISION OF PAROLE, RESPONDENT.

WYOMING COUNTY-ATTICA LEGAL AID BUREAU, WARSAW (LEAH RENE NOWOTARSKI OF COUNSEL), FOR PETITIONER.

ERIC T. SCHNEIDERMAN, ATTORNEY GENERAL, ALBANY (ZAINAB A. CHAUDHRY OF COUNSEL), FOR RESPONDENT.

Proceeding pursuant to CPLR article 78 (transferred to the Appellate Division of the Supreme Court in the Fourth Judicial Department by order of the Supreme Court, Wyoming County [Mark H. Dadd, A.J.], entered June 23, 2011) to review a determination of respondent. The determination revoked petitioner’s release to parole supervision.
It is hereby ORDERED that said proceeding is unanimously dismissed without costs as moot ( see Darnel v David , 300 AD2d 766, 767).

Entered: December 23, 2011 Frances E. Cafarell Clerk of the Court
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-1999
<PERIOD-START>                             OCT-01-1999             JAN-01-1999
<PERIOD-END>                               DEC-31-1999             DEC-31-1999
<CASH>                                           7,471                   7,471
<SECURITIES>                                        62                      62
<RECEIVABLES>                                      489                     489
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                 8,120                   8,120
<PP&E>                                           6,686                   6,686
<DEPRECIATION>                                   1,596                   1,596
<TOTAL-ASSETS>                                  39,786                  39,786
<CURRENT-LIABILITIES>                            4,245                   4,245
<BONDS>                                          8,673                   8,673
<PREFERRED-MANDATORY>                            1,110                   1,110
<PREFERRED>                                          0                       0
<COMMON>                                        11,448                  11,448
<OTHER-SE>                                       5,318                   5,318
<TOTAL-LIABILITY-AND-EQUITY>                    39,786                  39,786
<SALES>                                            693                   2,695
<TOTAL-REVENUES>                                   693                   2,695
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                                   829                   3,066
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                 136                     449
<INCOME-PRETAX>                                  5,937                   6,731
<INCOME-TAX>                                     2,284                   3,217
<INCOME-CONTINUING>                              3,653                   3,514
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                      17
<CHANGES>                                            0                       0
<NET-INCOME>                                     3,653                   3,531
<EPS-BASIC>                                       5.79                    5.62
<EPS-DILUTED>                                     5.55                    5.32


</TABLE>
<PAGE>

                                                                    EXHIBIT 99.2

                            CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report on Form 10-Q of First Robinson Financial
Corporation (the "Company") for the quarterly period ending September 30, 2002
as filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Jamie E. McReynolds, Chief Financial Officer of the Company,
certify, pursuant to section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1) the Report fully complies with the requirements of section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

     (2) the information contained in the Report fairly presents, in all
         material respects, the financial condition and result of operations of
         the Company.



By: /s/ Jamie E. McReynolds
    -----------------------
Name:  Jamie E. McReynolds
Chief Financial Officer
November 14, 2002








                                       26
From: lkfransen@charter.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:11:41 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Luther Fransen

Medford, OR 97504
EXHIBIT 10.3







 


 








 


AMENDMENT TO


EMPLOYMENT AGREEMENT


 


WHEREAS, Derma Sciences, Inc. (“Employer”)
and Edward J. Quilty (“Employee”) are parties to that certain Employment Agreement dated as of March 7, 2012
(the “Agreement”).


 


WHEREAS, Employer and Employee desire to
amend the Agreement to remove Employee’s ability to receive severance benefits upon Employee’s voluntary termination
of employment within six months of the occurrence of a change in control of Employer.


 


NOW, THEREFORE, in consideration of the
recitals set forth above, and for other good and valuable consideration, the adequacy and sufficiency of which are hereby acknowledged,
Employer and Employee agree that the Agreement be amended as follows:


 


1.      Section 7 of the Agreement is hereby
deleted in its entirety.


 


2.      Sections 8, 9, 10 and 11 of the Agreement
are hereby re-numbered as Sections 7, 8, 9 and 10, respectively.


 


3.      The second sentence of Section 7 of the Agreement is
hereby amended to read in its entirety as follows:


 


This Agreement is intended to comply with the requirements
of Section 409A of the Internal Revenue Code and the regulations thereunder (“Section 409A”).


 


4.      Section 8 of
the Agreement (Option Exercise Extension) is hereby amended to read in its entirety as follows:


 


In the event that Employer, without cause, either terminates
Employee’s employment or fails to renew this Agreement upon expiration hereof, then the period to exercise any option to
purchase the securities of Employer of which Employee may be possessed shall be extended to the earlier to occur of (i) the expiration
thereof as set forth in the option instrument or (ii) the 10th anniversary of the original date of grant.


 


Except as set forth herein, all of the other provisions of the
Agreement shall remain in effect.


 


This amendment may be executed in one or more counterparts,
each of which shall be deemed an original and all of which together shall be considered one and the same agreement.


 


[SIGNATURE PAGE FOLLOWS]


 



    	 



    	 



    

 


 


 


IN WITNESS WHEREOF, the parties have signed
this amendment on the 20th day of December, 2012.


 




	 	 	DERMA SCIENCES, INC.
	 	 	 
	 		/s/  Stephen T. Wills
	 	 	By: Stephen T. Wills
Title: Lead Director, Derma Sciences
Board of Directors









	 	 	EMPLOYEE.
	 	 	 
	 		/s/   Edward J. Quilty
	 	 	Name: Edward J. Quilty



  


 








    	2
EXHIBIT 31.2

CERTIFICATION

 

          I, Hugh T. Regan, Jr., certify that: 

          1.    I have reviewed this quarterly report on Form 10-Q of inTEST Corporation; 

          2.    Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

          3.    Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

          4.    The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

        (a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 

        (b)  [Paragraph omitted pursuant to SEC Release Nos. 33-8238 and 34-47986];

        (c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

        (d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

          5.    The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors: 

        (a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 

        (b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 

Date: November 14, 2003/s/ Hugh T. Regan, Jr.